108 related articles for article (PubMed ID: 12112120)
1. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy.
Schuld A; Blum WF; Pollmächer T
Ann Neurol; 2002 May; 51(5):660; author reply 660-1. PubMed ID: 12112120
[No Abstract] [Full Text] [Related]
2. Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.
Tsukamoto H; Ishikawa T; Fujii Y; Fukumizu M; Sugai K; Kanbayashi T
Neuropediatrics; 2002 Feb; 33(1):51-2. PubMed ID: 11930279
[TBL] [Abstract][Full Text] [Related]
3. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.
Nishino S; Ripley B; Overeem S; Nevsimalova S; Lammers GJ; Vankova J; Okun M; Rogers W; Brooks S; Mignot E
Ann Neurol; 2001 Sep; 50(3):381-8. PubMed ID: 11558795
[TBL] [Abstract][Full Text] [Related]
4. Hypocretin levels in sporadic and familial cases of canine narcolepsy.
Ripley B; Fujiki N; Okura M; Mignot E; Nishino S
Neurobiol Dis; 2001 Jun; 8(3):525-34. PubMed ID: 11442359
[TBL] [Abstract][Full Text] [Related]
5. Hypocretin deficiency in familial symptomatic narcolepsy.
Melberg A; Ripley B; Lin L; Hetta J; Mignot E; Nishino S
Ann Neurol; 2001 Jan; 49(1):136-7. PubMed ID: 11198287
[No Abstract] [Full Text] [Related]
6. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
Khatami R; Maret S; Werth E; Rétey J; Schmid D; Maly F; Tafti M; Bassetti CL
Lancet; 2004 Apr; 363(9416):1199-200. PubMed ID: 15081654
[TBL] [Abstract][Full Text] [Related]
7. Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barré syndrome.
Kanbayashi T; Ishiguro H; Aizawa R; Saito Y; Ogawa Y; Abe M; Hirota K; Nishino S; Shimizu T
Psychiatry Clin Neurosci; 2002 Jun; 56(3):273-4. PubMed ID: 12047592
[TBL] [Abstract][Full Text] [Related]
8. On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy.
Mignot E; Chen W; Black J
Sleep; 2003 Sep; 26(6):646-9. PubMed ID: 14572113
[No Abstract] [Full Text] [Related]
9. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
Overeem S; Scammell TE; Lammers GJ
Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
[TBL] [Abstract][Full Text] [Related]
10. The level of hypocretin 1 (orexin A) in cerebrospinal fluid and the diagnosis of narcolepsy and other somnolent disorders.
Kunimoto M
Intern Med; 2003 Aug; 42(8):634-5. PubMed ID: 12924483
[No Abstract] [Full Text] [Related]
11. [Hypocretin (orexin) deficiency in narcolepsy-cataplexy].
Nevsímalová S; Vanková J; Sonka K; Faraco J; Rogers W; Overeem S; Mignot E
Sb Lek; 2000; 101(4):381-6. PubMed ID: 11702580
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.
Maeda T; Nagata K; Kondo H; Kanbayashi T
Sleep Med; 2006 Dec; 7(8):662. PubMed ID: 17097921
[No Abstract] [Full Text] [Related]
13. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients.
Dalal MA; Schuld A; Haack M; Uhr M; Geisler P; Eisensehr I; Noachtar S; Pollmächer T
Neurology; 2001 Jun; 56(12):1749-51. PubMed ID: 11425946
[TBL] [Abstract][Full Text] [Related]
14. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
[TBL] [Abstract][Full Text] [Related]
15. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.
Kanbayashi T; Inoue Y; Chiba S; Aizawa R; Saito Y; Tsukamoto H; Fujii Y; Nishino S; Shimizu T
J Sleep Res; 2002 Mar; 11(1):91-3. PubMed ID: 11869432
[TBL] [Abstract][Full Text] [Related]
16. [Nacrolepsy manifesting initially as cataplexy and sleep paralysis: usefulness of CSF hypocretin-1 examination for early diagnosis].
Kobayashi Y; Miyamoto M; Miyamoto T; Yamazaki K; Hirata K; Kanbayashi T; Shimizu T
Rinsho Shinkeigaku; 2002 Mar; 42(3):233-6. PubMed ID: 12474294
[TBL] [Abstract][Full Text] [Related]
17. [Excessive daytime sleepiness and low CSF orexin-A/hypocretin-I levels in a patient with probable progressive supranuclear palsy].
Hattori Y; Hattori T; Mukai E; Mori H; Mizuno Y; Kayukawa Y; Okada T; Kanbayashi T
No To Shinkei; 2003 Dec; 55(12):1053-6. PubMed ID: 14870576
[TBL] [Abstract][Full Text] [Related]
18. Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke.
Scammell TE; Nishino S; Mignot E; Saper CB
Neurology; 2001 Jun; 56(12):1751-3. PubMed ID: 11425947
[TBL] [Abstract][Full Text] [Related]
19. Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy.
Dalal MA; Schuld A; Pollmächer T
J Sleep Res; 2002 Sep; 11(3):273. PubMed ID: 12220324
[No Abstract] [Full Text] [Related]
20. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
Kubota H; Kanbayashi T; Tanabe Y; Ito M; Takanashi J; Kohno Y; Shimizu T
Sleep; 2003 Aug; 26(5):555-7. PubMed ID: 12938807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
